Complications of Pelvic Lymphadenectomy and Interstitial Irradiation of A2 Tumors
The topic of treatment of complications that occur after interstitial therapy for stage A2 adenocarcinoma of the prostate is somewhat unique. While a number of series have studied complications after radiation therapy based on field size, dose delivered, dose fractions, and anatomic and physiologic characteristics of the host, rarely have they categorized complications of therapy based on pretreatment clinical stage. This I seek to do here on the basis of my experience with interstitial implantation with the 125I isotope in 126 patients at Eastern Virginia Medical School, Norfolk, Virginia (USA). Complications after interstitial therapy are divided into
acute, those that occur within the first 3 months, and
chronic, those that persist beyond 3 months or occur at some interval greater than 3 months after therapy.
KeywordsAdenocarcinoma Iodine Pneumonia Proctitis Phlebitis
Unable to display preview. Download preview PDF.
- 2.Anderson LL, Kuan HM, Ding IY (1980) Clinical dosimetry with I-125. In: Modern interstitial and intercavitary radiation cancer management. Masson, New York, chap 2Google Scholar
- 7.Folwer JE, Barzell W, Hilaris BS, Whitmore WF (1979) Complications of I-125 iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. J Urol 121:447Google Scholar
- 10.Lai PP, Shapiro SJ, Perez CA (1989) Carcinoma of the prostate stage B and C: influence of duration of radiotherapy. Proceedings of the American Society for Therapeutic Radiology and Oncology, 31st Annual Meeting, Abstract # 96Google Scholar
© Springer-Verlag Berlin Heidelberg 1991